Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.
暂无分享,去创建一个
C. Vargeese | C. Bell | D. Jellinek | W. Pieken | C Vargeese | L S Green | C Bell | L. Green | C. K. Lynott | C K Lynott | D. McGee | D Jellinek | N Gill | G Kirschenheuter | D P McGee | P Abesinghe | W A Pieken | G. Kirschenheuter | N. Gill | P. Abesinghe
[1] L. Gold,et al. Oligonucleotides as Research, Diagnostic, and Therapeutic Agents(*) , 1995, The Journal of Biological Chemistry.
[2] H. Engelhard,et al. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. , 1994, Cancer research.
[3] M. Presta,et al. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[4] Y. Lin,et al. Modified RNA sequence pools for in vitro selection. , 1994, Nucleic acids research.
[5] N. Quarto,et al. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin , 1989, The Journal of cell biology.
[6] J. Taylor. An Introduction to Error Analysis , 1982 .
[7] C. Stein,et al. Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.
[8] T. Fan,et al. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions. , 1994, British Journal of Cancer.
[9] F. Eckstein,et al. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.
[10] R. Sasada,et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. , 1991, Cancer research.
[11] N. Janjić,et al. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.
[12] Y. Osada,et al. Inhibitory effects of a bacteria‐derived sulfated polysaccharide against basic fibroblast growth factor‐induced endothelial cell growth and chemotaxis , 1993, Journal of cellular physiology.
[13] M. Presta,et al. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.
[14] J. Lear,et al. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.
[15] P. Black,et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours , 1994, The Lancet.
[16] K. Matsumoto,et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Fiddes,et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.
[18] M. Rusnati,et al. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin‐like bFGF receptors , 1993, Journal of cellular physiology.
[19] J. Richie,et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.
[20] D. Williams,et al. 2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. , 1992, Biochemistry.
[21] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[22] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[23] M. Klagsbrun,et al. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Moscatelli,et al. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.
[25] F. Eckstein,et al. Polynucleotides containing 2'-amino-2'-deoxyribose and 2'-azido-2'-deoxyribose. , 1973, Biochemistry.
[26] V. Baldin,et al. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. , 1990, The EMBO journal.
[27] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[28] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[29] D. Rifkin,et al. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.
[30] N. Quarto,et al. Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets. , 1994, Biochemical pharmacology.
[31] A. Pardi,et al. High-resolution molecular discrimination by RNA. , 1994, Science.
[32] J. Feigon,et al. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[34] M Yarus,et al. Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.
[35] D. Rifkin,et al. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.
[36] J. G. Moffatt,et al. Synthesis of some pyrimidine 2'-amino-2'-deoxynucleosides. , 1971, The Journal of organic chemistry.
[37] J. Takahashi,et al. Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor , 1991, FEBS letters.
[38] T. D. Schneider,et al. Information content of binding sites on nucleotide sequences. , 1986, Journal of molecular biology.
[39] K. Jankowski,et al. Nucleoside conformation is determined by the electronegativity of the sugar substituent. , 1980, Nucleic acids research.
[40] L. Cousens,et al. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.
[41] M. Benezra,et al. Reversal of basic fibroblast growth factor-mediated autocrine cell transformation by aromatic anionic compounds. , 1992, Cancer research.
[42] J. Fiddes,et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.
[43] O. Uhlenbeck,et al. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. , 1987, Nucleic acids research.
[44] J. Latham,et al. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. , 1994, Nucleic acids research.
[45] F. Eckstein,et al. Facile synthesis of 2'-amino-2'-deoxyribofuranosylpurines , 1979 .
[46] J. Biernat,et al. Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product. , 1984, Nucleic acids research.
[47] D. Moscatelli,et al. The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.
[48] N. Janjić,et al. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Scaringe,et al. Chemical synthesis of biologically active oligoribonucleotides using beta-cyanoethyl protected ribonucleoside phosphoramidites. , 1990, Nucleic acids research.
[50] B. Olwin,et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.
[51] N. S. Mcnutt,et al. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. , 1994, The American journal of pathology.
[52] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[53] D. Moscatelli,et al. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. , 1992, The Journal of biological chemistry.
[54] D. Rifkin,et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases , 1989, The Journal of cell biology.
[55] L. Gold,et al. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. , 1992, Journal of molecular biology.
[56] D. Gospodarowicz,et al. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. , 1985, The Journal of biological chemistry.
[57] J. Massagué,et al. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. , 1985, The Journal of biological chemistry.
[58] Fritz Eckstein,et al. Oligonucleotide duplexes containing 2'-amino-2'-deoxycytidines: thermal stability and chemical reactivity [published erratum appears in Nucleic Acids Res 1994 Feb 25;22(4): 701] , 1994, Nucleic Acids Res..
[59] A. Rapraeger,et al. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. , 1993, Journal of cell science.
[60] T. Kurokawa,et al. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property , 1993, Molecular and cellular biology.
[61] T. Maione,et al. Development of angiogenesis inhibitors for clinical applications. , 1990, Trends in pharmacological sciences.
[62] L. Kan,et al. Syntheses and Interactions of Oligodeoxyribonucleotides Containing 2′-Amino-2′-Deoxyuridine , 1993 .